Adapting and Pilot Testing a Loneliness Intervention for Cancer Survivors

Part of paid clinical trials in Seattle, Washington.

Sponsor
University of Washington
Study ID
NCT07418437
Status
Enrolling By Invitation

Conditions

  • Cancer Survivorship
  • Loneliness

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Social Prescribing Group — BEHAVIORAL
    Those in the Social Navigation intervention group will meet with the facilitator through a virtual visit (HIPAA-compliant videoconferencing or phone call based on patient preference) over the course of 9 weeks. Each virtual visit will last approximately 60 minutes. During the group intake visit, the facilitator will guide participants to complete an inventory of the participant's existing social network, former social network, and interests. Using this, in the second visit, the facilitator will work with the participants one-on-one to develop an action plan to promote, establish or re-establish social connections. The action plan will be referenced and refined throughout the course of the following 7 weeks. They will suggest specific social activities and connect patients to resources such as, community-based organizations or local social groups matched to individual participant interest to assist with social connection.
  • Usual Care — BEHAVIORAL
    Those randomized to the Usual Care group will receive usual care from their primary care clinician. At the conclusion of the study (after the final outcomes are collected), they will be offered a list of possible community-based organizations for social connection.

Study Details

Loneliness, which is the perceived lack of social support and connection, has increased substantially in the past decade and is adversely affecting the health and wellbeing of cancer survivors. The study seeks to test an intervention that builds on the principles of social prescribing, and targets loneliness to determine if it improves overall wellness and quality of life among cancer survivors.

Key Dates

Start date
Mar 9, 2026
Status verified
Feb 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
36 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Social Prescribing Group
    Participants will be randomized to the Social Prescribing group (N=18). Social Prescribing group participants will meet for 60 mins via Zoom, for 9-weeks.
  • Experimental: Usual Care Group
    Participants will be randomized to the Usual Care group (N=18). Participants in this group will resume to their usual standard of care for 9 weeks.

Primary Outcome Measure

Loneliness [ Time Frame: Baseline, 9 Weeks, 2 Month Follow Up ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of WashingtonSeattleWashington98105-

Find similar trials in Seattle, WA

By research site
University of Washington· Seattle, WA

Related Studies